Personalized gene testing to guide cancer treatment choices
Part of Cancer clinical trials.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can let the study use your stored tumor tissue, even if it gets used up
- You can provide a new tumor sample (biopsy or surgery), or you may have enough stored tissue
- You agree to a blood test (or similar sample) to check inherited gene changes
- You’re an adult (18+) and well enough for treatment studies (ECOG 0–1)
- You have measurable cancer that can be tracked, and your organs are healthy enough for study tests
- You agree to data sharing, follow-up updates, and you’re willing to receive findings that could affect treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
This trial investigates genetic testing (mutational profiling) in people with various advanced cancers. It aims to understand how these tests can guide more personalized treatment decisions.
This study tests if early genetic testing of your tumor can help find targeted treatments for advanced cancers that are hard to treat, such as pancreatic, liver, or triple-negative breast cancer. It aims to match you with a therapy based on your tumor's genetic profile.
This study looks at whether using a detailed genetic test of your tumor can help pick the best first or second treatment for advanced lung, colon, breast, or bladder cancer. The goal is to see if this personalized approach helps people live longer.
This study collects and analyzes genetic information from tissue or blood samples to help understand cancer and related inherited (family) risk. It may involve testing results being shared with you or your care team, depending on what samples are available.
Hear when a new Metastatic Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.